$SOND
Sonder Holdings Inc. Stock $sond

$sond Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000181939523000029 Filed on March 16, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$120.7M	$134.8M	$461.1M
YoY Change	50.05%	55.51%
Cost Of Revenue	$15.63M	$87.22M	$317.2M
YoY Change	51.84%	891.97%	1171.56%
Gross Profit	$105.1M	$47.55M	$143.9M
YoY Change	49.79%	-38.94%	-30.82%
Gross Profit Margin	87.05%	35.28%	31.21%
Selling, General & Admin	$48.58M	$47.15M	$183.7M
YoY Change	4.61%	-51.38%	-41.53%
% of Gross Profit	46.22%	99.17%	127.64%
Research & Development	$6.580M	$6.247M	$28.90M
YoY Change	-13.7%	-0.26%	51.36%
% of Gross Profit	6.26%	13.14%	20.08%
Depreciation & Amortization	$7.048M	$6.110M	$23.91M
YoY Change	25.19%	21.59%	34.98%
% of Gross Profit	6.71%	12.85%	16.62%
Operating Expenses	$55.16M	$106.6M	$212.6M
YoY Change	2.02%	-27.19%	-54.57%
Operating Profit	-$84.74M	-$59.07M	-$286.6M
YoY Change	-11.51%	-13.84%	3119.52%
Interest Expense	-$5.707M	-$2.327M	-$21.51M
YoY Change	-30.42%	-83.91%	-51.22%
% of Operating Profit
Other Income/Expense, Net	-$1.607M	$6.486M	$121.4M
YoY Change	-101.36%	13.27%	1127.53%
Pretax Income	-$86.35M	-$54.92M	-$165.2M
YoY Change	-485.1%	-28.95%	1461.68%
Income Tax	$81.00K	-$31.00K	$533.0K
% Of Pretax Income
Net Earnings	-$86.43M	-$54.23M	-$165.7M
YoY Change	-485.99%	-29.86%	1466.72%
Net Earnings / Revenue	-71.59%	-40.24%	-35.95%
Basic Earnings Per Share	-$0.39		-$0.80
Diluted Earnings Per Share	-$0.39	-$0.25	-$0.80
COMMON SHARES
Basic Shares Outstanding	219.3M shares	218.1M shares	206.0M shares
Diluted Shares Outstanding	219.1M shares		206.0M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$218.0M	$246.6M	$246.6M
YoY Change	-46.36%	253.7%	253.7%
Cash & Equivalents	$218.0M	$246.6M
Short-Term Investments
Other Short-Term Assets	$12.71M	$10.07M	$60.69M
YoY Change	-31.37%	-38.69%	146.55%
Inventory
Prepaid Expenses
Receivables	$6.990M	$5.613M	$5.613M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$271.2M	$312.9M	$312.9M
YoY Change	-39.01%	216.15%	216.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$35.43M	$34.93M	$1.224B
YoY Change	0.54%	27.18%	4358.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.79M	$16.27M	$16.27M
YoY Change	-11.63%	-26.17%	-26.17%
Total Long-Term Assets	$1.250B	$1.261B	$1.241B
YoY Change	5.54%	2446.94%	2406.65%
TOTAL ASSETS
Total Short-Term Assets	$271.2M	$312.9M	$312.9M
Total Long-Term Assets	$1.250B	$1.261B	$1.241B
Total Assets	$1.521B	$1.574B	$1.554B
YoY Change	-6.62%	959.82%	946.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.09M	$16.08M	$16.08M
YoY Change	-12.51%	-15.78%	-15.78%
Accrued Expenses	$18.23M	$20.13M	$178.7M
YoY Change	-27.98%	2.94%	538.96%
Deferred Revenue	$58.42M	$41.66M
YoY Change	71.49%	121.49%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$279.7M	$250.6M	$250.9M
YoY Change	21.66%	-4.93%	-4.84%
LONG-TERM LIABILITIES
Long-Term Debt	$179.7M	$173.0M	$173.0M
YoY Change	14.64%	1510.94%	1510.94%
Other Long-Term Liabilities	$2.043M	$3.430M	$1.147B
YoY Change	-94.42%	-12.19%	1537.64%
Total Long-Term Liabilities	$181.7M	$176.4M	$1.320B
YoY Change	-6.01%	1104.62%	1534.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$279.7M	$250.6M	$250.9M
Total Long-Term Liabilities	$181.7M	$176.4M	$1.320B
Total Liabilities	$1.618B	$1.594B	$1.571B
YoY Change	8.31%	362.7%	356.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.067B	-$980.6M
YoY Change	34.65%	20.34%
Common Stock	$21.00K	$21.00K
YoY Change	2000.0%	2000.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$96.83M	-$19.95M	-$17.12M
YoY Change
Total Liabilities & Shareholders Equity	$1.521B	$1.574B	$1.554B
YoY Change	-6.62%	959.82%	946.39%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$86.43M	-$54.23M	-$165.7M
YoY Change	-485.99%	-29.86%	1466.72%
Depreciation, Depletion And Amortization	$7.048M	$6.110M	$23.91M
YoY Change	25.19%	21.59%	34.98%
Cash From Operating Activities	-$35.49M	-$24.92M	-$149.0M
YoY Change	-29.99%	-42.64%	5481.2%
INVESTING ACTIVITIES
Capital Expenditures	$6.924M	$4.618M	$28.20M
YoY Change	-34.3%	-156.84%	-274.48%
Acquisitions
YoY Change
Other Investing Activities	-$554.0K	-$286.0K	-$2.796M
YoY Change	-48.56%	-82.24%	-48.47%
Cash From Investing Activities	-$7.478M	-$4.904M	-$30.99M
YoY Change	-35.62%	-49.63%	-93.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$24.68M
YoY Change
Cash From Financing Activities	$8.000K	44.00K	$400.6M
YoY Change	-100.0%	-100.72%	-11.54%
NET CHANGE
Cash From Operating Activities	-$35.49M	-24.92M	-$149.0M
Cash From Investing Activities	-$7.478M	-4.904M	-$30.99M
Cash From Financing Activities	$8.000K	44.00K	$400.6M
Net Change In Cash	-$42.78M	-29.78M	$219.2M
YoY Change	-112.69%	-49.77%	211467.23%
FREE CASH FLOW
Cash From Operating Activities	-$35.49M	-$24.92M	-$149.0M
Capital Expenditures	$6.924M	$4.618M	$28.20M
Free Cash Flow	-$42.42M	-$29.54M	-$177.2M
YoY Change	-30.73%	-16.37%	-1413.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	219282857	shares
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001819395
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AdditionalPaidInCapital
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94103
CY2022	dei	City Area Code CityAreaCode	(617)
CY2022	dei	Local Phone Number LocalPhoneNumber	300-0956
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	214700000	usd
CY2022	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2022	dei	Auditor Location AuditorLocation	San Francisco, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	246624000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69726000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	42562000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	215000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	972000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4127000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5613000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4638000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	0	usd
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	2957000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	8066000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	5029000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10065000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	16416000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	312930000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	98981000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34926000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27461000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1209486000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16270000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22037000	usd
CY2022Q4	us-gaap	Assets Assets	1573612000	usd
CY2021Q4	us-gaap	Assets Assets	148479000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16082000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19096000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20131000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19557000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	14418000	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	8412000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	41664000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18811000	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	0	usd
CY2021Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	13116000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	184636000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	158346000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	250641000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	263628000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1166538000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	usd
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	66132000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	172950000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3430000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1593559000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	568483000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	947601000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	43106000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12985000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7299000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-980554000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-814812000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-19947000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-764406000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1573612000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148479000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	461083000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	232944000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	115678000	usd
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	320016000	usd
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	201445000	usd
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	136995000	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	211081000	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	142728000	usd
CY2020	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	115072000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	132445000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	106135000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	77033000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28896000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19091000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17552000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	51224000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23490000	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12848000	usd
CY2020	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	359500000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-243822000	usd
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-6402000	usd
CY2022	son	Debt Conversion Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtConversionGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	29512000	usd
CY2021	son	Debt Conversion Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtConversionGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	0	usd
CY2020	son	Debt Conversion Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtConversionGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	0	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6171000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-249993000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	323000	usd
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-27.22
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-258670000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1643000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3841000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	120000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25247000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-294387000	usd
CY2021	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	1633000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-764406000	usd
CY2022	son	Adjustments To Additional Paid In Capital Liability Reclassified To Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalLiabilityReclassifiedToEquityComponentOfConvertibleDebt	2111000	usd
CY2022	son	Stock Issued During Period Value Conversion Of Notes StockIssuedDuringPeriodValueConversionOfNotes	159173000	usd
CY2022	son	Stock Issued During Period Value Conversion Of Preferred Stock StockIssuedDuringPeriodValueConversionOfPreferredStock	518761000	usd
CY2022	son	Stock Issued During Period Value Conversion Of Common Stock Reverse Recapitalization StockIssuedDuringPeriodValueConversionOfCommonStockReverseRecapitalization	267362000	usd
CY2022	son	Stock Issued During Period Value Spac Warrants Reverse Recapitalization StockIssuedDuringPeriodValueSPACWarrantsReverseRecapitalization	25985000	usd
CY2022	son	Stock Issued During Period Value Earnout Liability StockIssuedDuringPeriodValueEarnoutLiability	98117000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	49733000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1620000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	58000	usd
CY2022	son	Stock Issued During Period Value Conversion Of Exchangeable Stock StockIssuedDuringPeriodValueConversionOfExchangeableStock	1000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22957000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-165742000	usd
CY2022	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	5686000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-19947000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16969000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25247000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	7223000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	145250000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	0	usd
CY2021	us-gaap	Straight Line Rent StraightLineRent	-37525000	usd
CY2020	us-gaap	Straight Line Rent StraightLineRent	-1821000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-6590000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2387000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	245000	usd
CY2022	son	Capitalization Of Interest On Long Term Debt CapitalizationOfInterestOnLongTermDebt	18359000	usd
CY2021	son	Capitalization Of Interest On Long Term Debt CapitalizationOfInterestOnLongTermDebt	0	usd
CY2020	son	Capitalization Of Interest On Long Term Debt CapitalizationOfInterestOnLongTermDebt	0	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	151000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2378000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	716000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3802000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	35067000	usd
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2022	son	Debt Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	29512000	usd
CY2021	son	Debt Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	14834000	usd
CY2020	son	Debt Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	0	usd
CY2022	son	Fair Value Adjustment Of Warrants And Rights Outstanding FairValueAdjustmentOfWarrantsAndRightsOutstanding	0	usd
CY2021	son	Fair Value Adjustment Of Warrants And Rights Outstanding FairValueAdjustmentOfWarrantsAndRightsOutstanding	2148000	usd
CY2020	son	Fair Value Adjustment Of Warrants And Rights Outstanding FairValueAdjustmentOfWarrantsAndRightsOutstanding	26000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-25260000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	95700000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2206000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-810000	usd
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6335000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1693000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3067000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1681000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	3016000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-4991000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-4673000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-11903000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	23011000	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3865000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-28120000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8199000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3668000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10434000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10762000	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-590000	usd
CY2022	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	6074000	usd
CY2021	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	1366000	usd
CY2020	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	2062000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	22400000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	8643000	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4841000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-73858000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-151000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1329000	usd
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2499000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-149015000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-179391000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-202502000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28197000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16161000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12247000	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2796000	usd
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5426000	usd
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2603000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30993000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21587000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14850000	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	159225000	usd
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	27745000	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	18776000	usd
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	6741000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	162366000	usd
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	24366000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	325928000	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	58555000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1746000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3841000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1643000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	120000	usd
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	1020000	usd
CY2020	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	207293000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	400599000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	148571000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	226561000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1346000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-760000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-347000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	219245000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-53167000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8862000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69941000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	123108000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114246000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289186000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69941000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	123108000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	490000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	300000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	100000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2486000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	4550000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	5428000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	306000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	44000	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022	us-gaap	Notes Reduction NotesReduction	159172000	usd
CY2021	us-gaap	Notes Reduction NotesReduction	0	usd
CY2020	us-gaap	Notes Reduction NotesReduction	0	usd
CY2022	son	Noncash Or Part Noncash Acquisition Conversion Of Warrants Amount NoncashOrPartNoncashAcquisitionConversionOfWarrantsAmount	1243000	usd
CY2021	son	Noncash Or Part Noncash Acquisition Conversion Of Warrants Amount NoncashOrPartNoncashAcquisitionConversionOfWarrantsAmount	0	usd
CY2020	son	Noncash Or Part Noncash Acquisition Conversion Of Warrants Amount NoncashOrPartNoncashAcquisitionConversionOfWarrantsAmount	0	usd
CY2022	son	Conversion Of Stock Warrants Amount Converted ConversionOfStockWarrantsAmountConverted	2111000	usd
CY2021	son	Conversion Of Stock Warrants Amount Converted ConversionOfStockWarrantsAmountConverted	0	usd
CY2020	son	Conversion Of Stock Warrants Amount Converted ConversionOfStockWarrantsAmountConverted	0	usd
CY2022	son	Noncash Or Part Noncash Acquisition Derivative Liabilities Assumed NoncashOrPartNoncashAcquisitionDerivativeLiabilitiesAssumed	98117000	usd
CY2021	son	Noncash Or Part Noncash Acquisition Derivative Liabilities Assumed NoncashOrPartNoncashAcquisitionDerivativeLiabilitiesAssumed	0	usd
CY2020	son	Noncash Or Part Noncash Acquisition Derivative Liabilities Assumed NoncashOrPartNoncashAcquisitionDerivativeLiabilitiesAssumed	0	usd
CY2022	son	Recognition Of Spac Warrants Reverse Recapitalization RecognitionOfSPACWarrantsReverseRecapitalization	38135000	usd
CY2021	son	Recognition Of Spac Warrants Reverse Recapitalization RecognitionOfSPACWarrantsReverseRecapitalization	0	usd
CY2020	son	Recognition Of Spac Warrants Reverse Recapitalization RecognitionOfSPACWarrantsReverseRecapitalization	0	usd
CY2022	son	Noncash Or Part Cash Transaction Issuance Of Delayed Draw Warrants NoncashOrPartCashTransactionIssuanceOfDelayedDrawWarrants	5598000	usd
CY2021	son	Noncash Or Part Cash Transaction Issuance Of Delayed Draw Warrants NoncashOrPartCashTransactionIssuanceOfDelayedDrawWarrants	0	usd
CY2020	son	Noncash Or Part Cash Transaction Issuance Of Delayed Draw Warrants NoncashOrPartCashTransactionIssuanceOfDelayedDrawWarrants	0	usd
CY2022	son	Conversion Of Post Combination Exchangeable Shares ConversionOfPostCombinationExchangeableShares	49733000	usd
CY2021	son	Conversion Of Post Combination Exchangeable Shares ConversionOfPostCombinationExchangeableShares	0	usd
CY2020	son	Conversion Of Post Combination Exchangeable Shares ConversionOfPostCombinationExchangeableShares	0	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	518750000	usd
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2020	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	246624000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69726000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	121467000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	42562000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	215000	usd
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1641000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289186000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69941000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	123108000	usd
CY2022Q4	son	Number Of Variable Interest Entities NumberOfVariableInterestEntities	1	variableinterestentity
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:0.08pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Use of Estimates</span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expense during the reporting periods. Such significant management estimates include the fair value of share-based awards, estimated useful life of software development costs, bad-debt allowances, valuation of intellectual property and intangible assets, contingent liabilities, valuation allowance for deferred tax assets, and valuation of non-routine complex transactions, such as recognition of the Earn Out Liability and SPAC Warrants, among others. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from those estimates.</span></div>
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	232944000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	115678000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	42600000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
CY2021Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	8000000	usd
CY2022Q4	son	Deferred Transaction Costs Non Current DeferredTransactionCostsNonCurrent	0	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash. The Company places the majority of its cash with financial institutions in the United States that it believes to be of high credit quality and, accordingly, believes minimal credit risk exists with respect to these instruments. Certain of the Company’s cash balances held with financial institutions are in excess of Federal Deposit Insurance Corporation limits. The Company believes no significant concentration risk exists with respect to its cash.
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Reclassification</span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Certain amounts reported in previous consolidated financial statements have been reclassified to conform to current period presentation. These reclassifications did not affect previously reported amounts of net income, total assets, or total stockholders’ deficit.</span></div>
CY2022	us-gaap	Advertising Expense AdvertisingExpense	6600000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	5500000	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	4900000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	461083000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	461083000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	232944000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	115678000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4127000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2570000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1622000	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	4719000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4777000	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3162000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	972000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4127000	usd
CY2022Q4	son	Furniture Fixtures And Equipment And Leasehold Improvement Allowances Current FurnitureFixturesAndEquipmentAndLeaseholdImprovementAllowancesCurrent	0	usd
CY2021Q4	son	Furniture Fixtures And Equipment And Leasehold Improvement Allowances Current FurnitureFixturesAndEquipmentAndLeaseholdImprovementAllowancesCurrent	8206000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	8092000	usd
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes	6728000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	928000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1165000	usd
CY2022Q4	son	Current Assets Other CurrentAssetsOther	1045000	usd
CY2021Q4	son	Current Assets Other CurrentAssetsOther	317000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10065000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	16416000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11361000	usd
CY2022Q4	son	Debt Instrument Delayed Draw Warrants DebtInstrumentDelayedDrawWarrants	4945000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15417000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14010000	usd
CY2022Q4	son	Deferred Transaction Costs Non Current DeferredTransactionCostsNonCurrent	0	usd
CY2021Q4	son	Deferred Transaction Costs Non Current DeferredTransactionCostsNonCurrent	8027000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	666000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	0	usd
CY2022Q4	son	Non Current Assets Other NonCurrentAssetsOther	187000	usd
CY2021Q4	son	Non Current Assets Other NonCurrentAssetsOther	0	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16270000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22037000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5102000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5607000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1074000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	595000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2503000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13955000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10852000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20131000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19557000	usd
CY2021Q4	son	Debt Instrument Delayed Draw Warrants DebtInstrumentDelayedDrawWarrants	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	5350000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	625000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	172950000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	10736000	usd
CY2022	son	Noncash Or Part Noncash Acquisition Derivative Liabilities Assumed NoncashOrPartNoncashAcquisitionDerivativeLiabilitiesAssumed	98117000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	95700000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	101189000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	71898000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	66263000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	44437000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34926000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27461000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	23900000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	17700000	usd
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	17000000	usd
CY2022	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	2600000	usd
CY2021	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	2500000	usd
CY2020	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	12700000	usd
CY2022	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	-2100000	usd
CY2021	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	-1800000	usd
CY2020	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	-8800000	usd
CY2020	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-300000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	183245000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	268810000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3203000	usd
CY2022	us-gaap	Variable Lease Income VariableLeaseIncome	2582000	usd
CY2022	us-gaap	Lease Cost LeaseCost	269431000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	218434000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	356157000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M4D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.098
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	297127000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	294595000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	275297000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	250188000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	205674000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	653992000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1976873000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	642277000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1334596000	usd
CY2022Q4	son	Operating Lease Liability Allowances For Leases Not Yet Commenced OperatingLeaseLiabilityAllowancesForLeasesNotYetCommenced	9700000	usd
CY2022Q4	son	Lessee Operating Lease Lease Not Yet Commenced Future Lease Payments LesseeOperatingLeaseLeaseNotYetCommencedFutureLeasePayments	1900000000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	268800000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	184800000	usd
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	133100000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	279093000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	366299000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	418156000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	433541000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	403582000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1641237000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3541908000	usd
CY2022Q1	son	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4686
CY2022Q4	son	Shares Authorized SharesAuthorized	690000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	126055660	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	230720775	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22957000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25247000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7223000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	19772797	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.96
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y11M19D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19219000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16654385	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.66
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2225859	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.72
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2462473	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.13
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1032001	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.06
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30706850	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.55
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y5M23D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	107556000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12584308	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.96
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	931362	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.68
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5140606	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.18
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	540183	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.10
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36679007	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.99
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M17D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	87512000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11685136	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.32
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M8D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	87512000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	36679007	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.99
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y7M17D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	87512000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.93
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.99
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.60
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2700000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14500000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3300000	usd
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Estimated Price CommonStockCapitalSharesMarketCapitalisationEstimatedPrice	5000000000	usd
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Estimated Per Share CommonStockCapitalSharesMarketCapitalisationEstimatedPerShare	18.05
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Adjustments Price CommonStockCapitalSharesMarketCapitalisationAdjustmentsPrice	5000000000	usd
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Adjustments Per Share CommonStockCapitalSharesMarketCapitalisationAdjustmentsPerShare	5.27
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Option Award Market Price Per Share Year One CommonStockCapitalSharesMarketCapitalisationOptionAwardMarketPricePerShareYearOne	15.20
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Option Award Market Price Per Share Year Two CommonStockCapitalSharesMarketCapitalisationOptionAwardMarketPricePerShareYearTwo	21.10
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Option Award Market Price Per Share Year Three CommonStockCapitalSharesMarketCapitalisationOptionAwardMarketPricePerShareYearThree	24.05
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Option Award Adjusted Market Price Per Share Year Three CommonStockCapitalSharesMarketCapitalisationOptionAwardAdjustedMarketPricePerShareYearThree	4.53
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Option Award Adjusted Market Price Per Share Year Four CommonStockCapitalSharesMarketCapitalisationOptionAwardAdjustedMarketPricePerShareYearFour	6.39
CY2022Q4	son	Common Stock Capital Shares Market Capitalisation Option Award Adjusted Market Price Per Share Year Five CommonStockCapitalSharesMarketCapitalisationOptionAwardAdjustedMarketPricePerShareYearFive	7.14
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-294145000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-249993000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	4097000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8360000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5284000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-165742000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-294387000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-250316000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-165742000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-294387000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-250316000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	206037605	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11765912	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9195258	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	206037605	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11765912	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9195258	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-25.02
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-27.22
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-25.02
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-27.22
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	152091000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	6136000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	4936000	usd
CY2022Q4	son	Deferred Tax Assets Fixed And Intangible Assets DeferredTaxAssetsFixedAndIntangibleAssets	18601000	usd
CY2021Q4	son	Deferred Tax Assets Fixed And Intangible Assets DeferredTaxAssetsFixedAndIntangibleAssets	17870000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	9128000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	10776000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	6245000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	9257000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	82733258	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	176680745	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	169928182	shares
CY2022	son	Number Of Surety Providers NumberOfSuretyProviders	5	surety_provider
CY2022Q4	son	Loss Contingency Estimated Accrual Liability Related To Tax Matters LossContingencyEstimatedAccrualLiabilityRelatedToTaxMatters	7900000	usd
CY2021Q4	son	Loss Contingency Estimated Accrual Liability Related To Tax Matters LossContingencyEstimatedAccrualLiabilityRelatedToTaxMatters	4400000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	120000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	113000	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	104000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	413000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	129000	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	219000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	533000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	242000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	323000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-94544000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-261852000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-148332000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-70665000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-32293000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-101661000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-165209000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-34695000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-61771000	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-52499000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1528000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-7645000	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-889000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	95000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	89000	usd
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-8553000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	873000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1753000	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1214000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1823000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1389000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	66000	usd
CY2022	son	Effective Income Tax Rate Reconciliation Convertible Debt Instruments EffectiveIncomeTaxRateReconciliationConvertibleDebtInstruments	-31584000	usd
CY2021	son	Effective Income Tax Rate Reconciliation Convertible Debt Instruments EffectiveIncomeTaxRateReconciliationConvertibleDebtInstruments	5399000	usd
CY2020	son	Effective Income Tax Rate Reconciliation Convertible Debt Instruments EffectiveIncomeTaxRateReconciliationConvertibleDebtInstruments	0	usd
CY2022	son	Effective Income Tax Rate Reconciliation Capital Loss EffectiveIncomeTaxRateReconciliationCapitalLoss	16105000	usd
CY2021	son	Effective Income Tax Rate Reconciliation Capital Loss EffectiveIncomeTaxRateReconciliationCapitalLoss	-9640000	usd
CY2020	son	Effective Income Tax Rate Reconciliation Capital Loss EffectiveIncomeTaxRateReconciliationCapitalLoss	0	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-434000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-2362000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	220000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	51624000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	76536000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	63192000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	533000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	242000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	323000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	172955000	usd
CY2022Q4	son	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	271846000	usd
CY2021Q4	son	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	13985000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5892000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	511916000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	205543000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	262638000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	205543000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	249278000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	249278000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	57100000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	83500000	usd
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	63200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	41000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	479300000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1353000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	683000	usd
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	20000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	417000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	383000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	274000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	253000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	300000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	127000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1520000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1353000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	683000	usd
CY2022	son	Reverse Recapitalization Net ReverseRecapitalizationNet	401900000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24700000	usd
CY2022	son	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	58600000	usd
CY2022	son	Reverse Recapitalization Net ReverseRecapitalizationNet	401900000	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	159200000	usd
CY2022Q4	son	Extension Of Post Exchangeable Shares Period ExtensionOfPostExchangeableSharesPeriod	P5Y
CY2022	son	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	58555000	usd
CY2022	son	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	267373000	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	159225000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24680000	usd
CY2022	son	Reverse Recapitalization Net ReverseRecapitalizationNet	401918000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	4000000	usd

Files In Submission

Name	View Source	Status
0001819395-23-000029-index-headers.html	Edgar Link	pending
0001819395-23-000029-index.html	Edgar Link	pending
0001819395-23-000029.txt	Edgar Link	pending
0001819395-23-000029-xbrl.zip	Edgar Link	pending
exhibit1029-firstamendme.htm	Edgar Link	pending
exhibit1029-firstamendme001.jpg	Edgar Link	pending
exhibit1029-firstamendme002.jpg	Edgar Link	pending
exhibit1029-firstamendme003.jpg	Edgar Link	pending
exhibit1029-firstamendme004.jpg	Edgar Link	pending
exhibit1029-firstamendme005.jpg	Edgar Link	pending
exhibit1029-firstamendme006.jpg	Edgar Link	pending
exhibit1029-firstamendme007.jpg	Edgar Link	pending
exhibit1029-firstamendme008.jpg	Edgar Link	pending
exhibit1029-firstamendme009.jpg	Edgar Link	pending
exhibit1029-firstamendme010.jpg	Edgar Link	pending
exhibit1029-firstamendme011.jpg	Edgar Link	pending
exhibit1029-firstamendme012.jpg	Edgar Link	pending
exhibit1029-firstamendme013.jpg	Edgar Link	pending
exhibit1029-firstamendme014.jpg	Edgar Link	pending
exhibit1029-firstamendme015.jpg	Edgar Link	pending
exhibit1029-firstamendme016.jpg	Edgar Link	pending
exhibit1029-firstamendme017.jpg	Edgar Link	pending
exhibit1029-firstamendme018.jpg	Edgar Link	pending
exhibit1029-firstamendme019.jpg	Edgar Link	pending
exhibit1029-firstamendme020.jpg	Edgar Link	pending
exhibit1029-firstamendme021.jpg	Edgar Link	pending
exhibit1029-firstamendme022.jpg	Edgar Link	pending
exhibit1029-firstamendme023.jpg	Edgar Link	pending
exhibit1029-firstamendme024.jpg	Edgar Link	pending
exhibit1029-firstamendme025.jpg	Edgar Link	pending
exhibit1029-firstamendme026.jpg	Edgar Link	pending
exhibit1029-firstamendme027.jpg	Edgar Link	pending
exhibit1029-firstamendme028.jpg	Edgar Link	pending
exhibit1029-firstamendme029.jpg	Edgar Link	pending
exhibit1029-firstamendme030.jpg	Edgar Link	pending
exhibit1029-firstamendme031.jpg	Edgar Link	pending
exhibit1029-firstamendme032.jpg	Edgar Link	pending
exhibit1029-firstamendme033.jpg	Edgar Link	pending
exhibit1029-firstamendme034.jpg	Edgar Link	pending
exhibit1029-firstamendme035.jpg	Edgar Link	pending
exhibit1029-firstamendme036.jpg	Edgar Link	pending
exhibit1029-firstamendme037.jpg	Edgar Link	pending
exhibit1029-firstamendme038.jpg	Edgar Link	pending
exhibit1029-firstamendme039.jpg	Edgar Link	pending
exhibit1029-firstamendme040.jpg	Edgar Link	pending
exhibit1029-firstamendme041.jpg	Edgar Link	pending
exhibit1029-firstamendme042.jpg	Edgar Link	pending
exhibit1029-firstamendme043.jpg	Edgar Link	pending
exhibit1029-firstamendme044.jpg	Edgar Link	pending
exhibit1029-firstamendme045.jpg	Edgar Link	pending
exhibit1029-firstamendme046.jpg	Edgar Link	pending
exhibit1029-firstamendme047.jpg	Edgar Link	pending
exhibit1029-firstamendme048.jpg	Edgar Link	pending
exhibit1029-firstamendme049.jpg	Edgar Link	pending
exhibit1029-firstamendme050.jpg	Edgar Link	pending
exhibit1029-firstamendme051.jpg	Edgar Link	pending
exhibit1029-firstamendme052.jpg	Edgar Link	pending
exhibit1029-firstamendme053.jpg	Edgar Link	pending
exhibit1029-firstamendme054.jpg	Edgar Link	pending
exhibit1029-firstamendme055.jpg	Edgar Link	pending
exhibit1029-firstamendme056.jpg	Edgar Link	pending
exhibit1029-firstamendme057.jpg	Edgar Link	pending
exhibit1029-firstamendme058.jpg	Edgar Link	pending
exhibit1029-firstamendme059.jpg	Edgar Link	pending
exhibit1029-firstamendme060.jpg	Edgar Link	pending
exhibit1029-firstamendme061.jpg	Edgar Link	pending
exhibit1029-firstamendme062.jpg	Edgar Link	pending
exhibit1029-firstamendme063.jpg	Edgar Link	pending
exhibit1029-firstamendme064.jpg	Edgar Link	pending
exhibit1029-firstamendme065.jpg	Edgar Link	pending
exhibit1029-firstamendme066.jpg	Edgar Link	pending
exhibit1029-firstamendme067.jpg	Edgar Link	pending
exhibit1029-firstamendme068.jpg	Edgar Link	pending
exhibit1029-firstamendme069.jpg	Edgar Link	pending
exhibit1029-firstamendme070.jpg	Edgar Link	pending
exhibit1029-firstamendme071.jpg	Edgar Link	pending
exhibit1029-firstamendme072.jpg	Edgar Link	pending
exhibit1029-firstamendme073.jpg	Edgar Link	pending
exhibit1029-firstamendme074.jpg	Edgar Link	pending
exhibit1029-firstamendme075.jpg	Edgar Link	pending
exhibit1029-firstamendme076.jpg	Edgar Link	pending
exhibit1029-firstamendme077.jpg	Edgar Link	pending
exhibit1029-firstamendme078.jpg	Edgar Link	pending
exhibit1029-firstamendme079.jpg	Edgar Link	pending
exhibit1029-firstamendme080.jpg	Edgar Link	pending
exhibit1029-firstamendme081.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl.htm	Edgar Link	pending
exhibit1030-sonderxsvbxl001.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl002.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl003.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl004.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl005.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl006.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl007.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl008.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl009.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl010.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl011.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl012.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl013.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl014.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl015.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl016.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl017.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl018.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl019.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl020.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl021.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl022.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl023.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl024.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl025.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl026.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl027.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl028.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl029.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl030.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl031.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl032.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl033.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl034.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl035.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl036.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl037.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl038.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl039.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl040.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl041.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl042.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl043.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl044.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl045.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl046.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl047.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl048.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl049.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl050.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl051.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl052.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl053.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl054.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl055.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl056.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl057.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl058.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl059.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl060.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl061.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl062.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl063.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl064.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl065.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl066.jpg	Edgar Link	pending
exhibit1030-sonderxsvbxl067.jpg	Edgar Link	pending
exhibit211-significantsubs.htm	Edgar Link	pending
exhibit231-sonderconsentxf.htm	Edgar Link	pending
exhibit311-sec302certifica.htm	Edgar Link	pending
exhibit312-sec302certifica.htm	Edgar Link	pending
exhibit321-sec906certifica.htm	Edgar Link	pending
exhibit322-sec906certifica.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
son-20221231.htm	Edgar Link	pending
son-20221231.xsd	Edgar Link	pending
son-20221231_g1.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
son-20221231_cal.xml	Edgar Link	unprocessable
son-20221231_def.xml	Edgar Link	unprocessable
son-20221231_lab.xml	Edgar Link	unprocessable
son-20221231_pre.xml	Edgar Link	unprocessable
son-20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SOND
Sonder Holdings Inc. Stock $sond

2023 Q1 Form 10-K Financial Statement

#000181939523000029 Filed on March 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOND Sonder Holdings Inc. Stock $sond

2023 Q1 Form 10-K Financial Statement

#000181939523000029 Filed on March 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOND
Sonder Holdings Inc. Stock $sond